A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Titel:
A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Auteur:
Dimopoulos, Meletios A. Coriu, Daniel Delimpasi, Sosana Špička, Ivan Upchurch, Terry Fang, Belle Talpur, Rakhshandra Faber, Edward Beksac, Meral Leleu, Xavier